The Biden administration today announced $1 billion in American Rescue Plan Act funding for the Centers for Disease Control and Prevention, states and other jurisdictions to expand genomic sequencing to detect and track COVID-19 variants, which it said now comprise about half of U.S. cases. 

The administration said it will distribute $240 million to jurisdictions in early May and a “second tranche” over several years. 

In addition, the administration said it will invest $400 million from ARPA to create six Centers of Excellence in Genomic Epidemiology with state health departments and academic institutions to research and develop genomic surveillance tools and other innovations; and $300 million to build a National Bioinformatics Infrastructure to share and analyze sequence data across the public health system. 
 

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…